Dr. HUSEYIN ENGIN (M) (G)

• 2003Hacettepe University Faculty of Medicine Medical Oncology
• 1999Hacettepe University Faculty of Medicine Internal Medicine
• 1994Hacettepe University Faculty of Medicine

Experience

• 2022Acıbadem Health Group
• 2021Şişli Hamidiye Etfal Training and Research Hospital / Prof. Dr.
• 2012 – 2021Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Prof. Dr.
• 2006 – 2012Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Assoc. Prof. Dr.
• 2004 – 2006Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Assoc. Prof. Dr.
• 2004Private Zonguldak A Medical Center, Zonguldak / Specialist Doctor
• 2003Burhan Nalbantoğlu State Hospital, Nicosia, TRNC / Specialist Doctor
• 1999 – 2003Hacettepe University Faculty of Medicine / Department of Internal Medicine / Department of Medical Oncology / Minor Assistant
• 1999 – 2003Tumor Biology and Immunology MSc Degree Program, Hacettepe University Oncology Institute, Basic Oncology Science Department / Special Student
• 1994 – 1999Hacettepe University Faculty of Medicine, Department of Internal Medicine / Res. Asst.

• Turkish Oncology Group Flims Alumni Club (FAC)
• ESMO (European Society for Medical Oncology)
• Turkish Internal Medicine Specialist Association
• Medical Oncology Association

• Intraoperative Ultrasonography-Guided Surgery; An effective modality for breast conservation after neo-adjuvant ehemotherapyBreast Journal. 2020;26:1680-1687 Taşdöven İ, Çakmak GK, Emre AU, Engin H. Bahadır B, Bakkal BH, Güllüoğlu MB.
• Serum Sulphate Levels in Hemodialysis PatientsInt J Nephrol. 2019 Dec 1;2019:1063514. doi: 10.1155/2019/1063514. eCollection 2019 Yildirim I, Hur E, Magden K, İlikhan S, Engin H, Can M, Yıldız G, Özer İ.
• Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospeetive analysisUrun Y. J BUON. 2018 Dec;23(7): 116-121. Ergun Y, Ozdemir NY, Guner EK, Esin E, Sendur MA, Koksoy EB, Demirci NS, Eren T, Dede I, Sezer A, Engin H, Oksuzoglu B, Yalcin B, Utkan G, Zengin N,
• The effects of zoledronic acid on ECG: a prospeetive study on patients with bone metastatic cancerClin Cases Miner Bone Metab. 2017 Jan-Apr; 14(1):35-39. doi: 10.11138/ccmbm/2017.14.1.035. Epub 2017 May 30. Demirtas D, Bilir C, Demirtas AO, Engin H.
• Efficacv of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance statusCurr Oncol. 2017 Jun;24(3):el99-e204. doi: 10.3747/co.24.3486. Epub 2017 Jun 27. Bilir C, Durak S, Kızılkaya B, Hacıbekiroglu I, Nayır E, Engin H.
• Prognostic value of total lesion glycolysis in stage IIIB/IV nonesmall celi lung cancer.Journal of Oncological Sciences 3 (2017) 107-11 Yusufoğlu B, Bilir C, Engin H.
• A Study on the Association Between Leptin and Leptin Receptor Gene Variants and Colorectal Cancer.Muğla Sıtkı Koçman University Medical Journal. 2017;4(1): 10-14. Korkmaz N, Kimyon AS, Ermiş E, Edgünlü T, Arpacı E, Engin H. Karakaş Çelik S.
• Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Celi Carcinoma: A Turkish Oncology Group (TOG) StudyClin Genitourin Cancer. 2016 Aug; 14(4):e347-53. Artaç M, Çoşkun HS, Korkmaz L, Koçer M, Turhal IMS, Engin H. Dede İ, Paydaş S, Oksuzoğlu B, Bozcuk H, Demirkazık A.
• 10. Red Celi Distribution Width Has a Predictable Value for Differentiation of Provoked and Unprovoked Venous ThromboembolismIndian J Hematol Blood Transfus. 2016 Dec;32(4):481-487. Ertop S, Bilici M, Engin H, Buyukuysal C, Arslaner M, Toka B, Tekin
• Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients vvith non- metastatic triple-negative breast cancerOncol Lett. 2015 Jun;9(6):2819-2824. Bilir C, Engin H, Can M, Likhan S, Demirtas D, Kuzu F, Bayraktaroglu T.